Oral Delivery of IL27 Recombinant Bacteria Attenuates Immune Colitis in Mice

समान संसाधन

• Interleukin 27 is a potential rescue therapy for acute severe colitis via interleukin-10 dependent, T cell independent attenuation of colonic mucosal innate immune responses
  द्वारा: McLean, Mairi H, और अन्य
  प्रकाशित: (2017)
• IL-27 as a novel therapy for inflammatory bowel disease: a critical review of the literature
  द्वारा: Andrews, Caroline, और अन्य
  प्रकाशित: (2016)
• IL-22-Expressing Murine Lymphocytes Display Plasticity and Pathogenicity in Reporter Mice
  द्वारा: Shen, Wei, और अन्य
  प्रकाशित: (2016)
• Cytokine Tuning of Intestinal Epithelial Function
  द्वारा: Andrews, Caroline, और अन्य
  प्रकाशित: (2018)
• Targeting Interleukins for the Treatment of Inflammatory Bowel Disease—What Lies Beyond Anti-TNF Therapy?
  द्वारा: McLean, Mairi H., और अन्य
  प्रकाशित: (2014)